Stay updated on Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial page.

Latest updates to the Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing the previous v3.6.4. This indicates an updated build/version label for the page content.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing v3.6.3, indicating a platform update. The underlying content and purpose of the page remain unchanged.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, indicating a minor update to the page content or structure. This change does not alter the study data or how a user interacts with the study record.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision label on the page footer changed from v3.6.0 to v3.6.2, indicating a newer page release. This reflects a minor update to the page tooling or formatting and does not imply a change to the study data or eligibility details.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page now shows a recruitment notice 'No longer looking for participants' and adds navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) alongside an updated Intervention/Treatment label. The older 'Intervention / Treatment' text and 'Revision: v3.5.5' have been removed, with the page revision updated to v3.6.0.SummaryDifference0.5%

- Check77 days agoChange DetectedThe page now displays Revision: v3.5.5, replacing the previous v3.5.4, indicating a small page/template update. No study content or user-facing details have been changed.SummaryDifference0.1%

Stay in the know with updates to Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial page.